Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its target price lifted by equities researchers at Mizuho from $197.00 to $201.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the financial services provider’s stock. Mizuho’s price objective indicates a potential upside of 13.52% from the company’s previous close.
Other research analysts have also recently issued research reports about the company. Morgan Stanley cut their price target on Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating on the stock in a research note on Monday, July 6th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Piper Sandler reduced their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Citigroup lowered shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price target for the company. in a research note on Wednesday. Finally, UBS Group upped their price target on shares of Marsh & McLennan Companies from $203.00 to $212.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $201.06.
Read Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Trading Down 2.5%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. On average, analysts anticipate that Marsh & McLennan Companies will post 10.36 EPS for the current year.
Insider Activity
In related news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Institutional Trading of Marsh & McLennan Companies
Institutional investors and hedge funds have recently modified their holdings of the business. Family Wealth Partners LLC bought a new position in Marsh & McLennan Companies in the second quarter worth about $219,000. Tema ETFs LLC raised its position in shares of Marsh & McLennan Companies by 9.5% during the 2nd quarter. Tema ETFs LLC now owns 10,029 shares of the financial services provider’s stock worth $1,672,000 after purchasing an additional 870 shares during the period. Handelsbanken Fonder AB lifted its holdings in shares of Marsh & McLennan Companies by 7.4% in the 2nd quarter. Handelsbanken Fonder AB now owns 215,758 shares of the financial services provider’s stock worth $35,960,000 after purchasing an additional 14,929 shares during the last quarter. Revolve Wealth Partners LLC acquired a new position in Marsh & McLennan Companies during the 2nd quarter valued at approximately $372,000. Finally, Franklin Parlapiano Turner & Welch LLC grew its stake in Marsh & McLennan Companies by 4.1% during the 2nd quarter. Franklin Parlapiano Turner & Welch LLC now owns 41,467 shares of the financial services provider’s stock worth $6,911,000 after buying an additional 1,643 shares during the last quarter. 87.99% of the stock is owned by institutional investors and hedge funds.
Marsh & McLennan Companies News Summary
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: MRSH reported Q2 earnings of $2.96 per share, topping estimates, with revenue of $7.28 billion and growth driven by consulting plus Risk & Insurance Services. Marsh (MRSH) Q2 Earnings and Revenues Top Estimates
- Positive Sentiment: One analyst note argued the company remains a buy after Q2, suggesting the quarter supports the longer-term investment case. Marsh & McLennan: Maintaining My ‘Buy’ Recommendation Following Q2 Earnings
- Neutral Sentiment: William Blair kept a neutral stance, saying Q2 was solid and growth is stabilizing, but valuation still looks expensive. Marsh & McLennan: Solid Q2 and Stabilizing Growth, But Valuation Keeps Analyst Firm at Hold
- Neutral Sentiment: Citigroup downgraded MRSH from buy to neutral, but still raised the price target to $200, implying some upside from current levels. Benzinga
- Negative Sentiment: Investors appear focused on valuation and slower growth outlook in the earnings call commentary, which may be capping enthusiasm after the beat. Marsh & McLennan Earnings Call Highlights Growth, Challenges
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
- Boxabl Disrupts Housing With A Tiny Float IPO
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
